Brain cancer treatment options boosted with Gamma Knife

August 24, 2012 By Cheryl Powell, Akron Beacon Journal

Until recently, Nanci Redd thought she would need brain surgery if she wanted to stay in Akron, Ohio, to treat uncontrolled dizziness caused by a non-cancerous growth in her head.

Instead, she's scheduled to be the first patient treated with Akron General Health System's new Leksell Gamma Knife Perfexion unit.

The $5 million machine uses precise beams of radiation instead of an actual knife to target and destroy and other cranial disorders while minimizing damage to healthy tissue.

Patients who previously required Gamma Knife procedures were referred to Cleveland hospitals.

"This is a service to the community," said Dr. Georges Z. Markarian, chairman of the Neurosciences Department at Akron General. "The technology is really important because it provides a level of care that doesn't exist in this form."

For Redd, a 66-year-old retired bus driver and grandmother from Akron, the Gamma Knife procedure is preferred over .

Without treatment, doctors warned her, the growth could eventually affect her hearing and swallowing.

"For me," she said, "it sounds so much better than surgery. They said I'll just be able to walk out of there by lunchtime."

The acquisition of the Gamma Knife is part of a $30 million investment the health system is making to boost its ability to treat patients with and neurological disorders, said Dr. Sarel "Charl" Vorster, medical director of the institute.

"You have to be able to handle the patient through the whole care cycle," Vorster said.

During Gamma Knife treatments, a , and physicist work together to determine how much radiation to use on the tumor and exactly where to direct it.

Patients receive a when a frame is attached to their head to keep it immobilized, Vorster said. They remain awake for the single treatment, which typically lasts 10 to 40 minutes.

The Gamma Knife can be a good option for some patients who have had lung, breast or other cancers spread to the brain, said Dr. Mitchel L. Fromm, chairman of the Department of Radiation Oncology at Akron General Medical Center.

The Gamma Knife also can be used to treat other brain and pituitary tumors, vascular malformations and functional disorders, such as some tremors and facial pain, Vorster said.

The precision allows minimal damage to nearby healthy tissue while destroying the tumor or malformation, Fromm said.

The goal is to "give as much as you can to the tumor but as little as you can to the normal tissue," Fromm said. "...Just imagine a firing squad with all the marksmen, all the people firing precisely hitting the target."

Explore further: Patients benefit from modern radiation technology

More information: (c)2012 Akron Beacon Journal (Akron, Ohio)
Visit the Akron Beacon Journal (Akron, Ohio) at
Distributed by MCT Information Services

Related Stories

Patients benefit from modern radiation technology

February 24, 2012
Patients with tumors and other life-threatening conditions are benefiting from the steady evolution of radiosurgery and radiotherapy, treatments that are often described as "incisionless surgery” or "surgery without ...

Latest advance in precise radiation treatment a powerful addition -- first in the nation

February 14, 2012
UT Southwestern Medical Center has installed a new system to deliver extremely precise and individualized radiation treatment, assuring that cancer patients in the region have access to the latest advances in radiation oncology.

World tallest man finally stops growing, US doctors say

March 16, 2012
Good news for Turkey's Sultan Kosen, at eight foot three (2.51 meters) the world's tallest living man: he can now say with confidence that he's finally grown up.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.